Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients

L. K. Sztriha, K. Sas, E. Seres, K. Boda, L. Lenti, G. Csifcsak, N. Kovács, L. Vécsei

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives - To investigate whether the results of optical platelet aggregometry indicate the risk of recurrent ischemic events. Materials and methods - Cerebro- and cardiovascular patients taking aspirin for at least 30 days were studied retrospectively. Ischemic vascular events occurring prior to testing and the presence of vascular risk factors were recorded. Results - 241 subjects were included. Among the 78 patients (32.4%) who displayed recurrent vascular episodes, the age (62.5 ± 10.6 vs. 58.4 ± 11.6, P = 0.009) and the proportion of hypertensives (80.8% vs. 68.1%, P = 0.040) were significantly higher when compared with the participants who exhibited single events. The degree of platelet aggregation did not differ significantly between the patients with and those without recurrent episodes. Logistic regression analysis identified only age (OR 1.033, 95% CI 1.008-1.058, P = 0.010), and not aggregation values, as a risk condition for recurrent vascular episodes. Conclusions - Results of optical platelet aggregometry were not indicative of the risk of recurrent vascular events. The role of conventional risk factors appeared to be more important.

Original languageEnglish
Pages (from-to)250-254
Number of pages5
JournalActa Neurologica Scandinavica
Volume117
Issue number4
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Aspirin
Blood Vessels
Blood Platelets
Platelet Aggregation
Logistic Models
Regression Analysis

Keywords

  • Aspirin resistance
  • Cerebrovascular diseases
  • Neuropharmacology
  • Strokes
  • Transient ischemic attack
  • Treatment
  • Vascular risk factors

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients. / Sztriha, L. K.; Sas, K.; Seres, E.; Boda, K.; Lenti, L.; Csifcsak, G.; Kovács, N.; Vécsei, L.

In: Acta Neurologica Scandinavica, Vol. 117, No. 4, 04.2008, p. 250-254.

Research output: Contribution to journalArticle

@article{8f7acb834fad4226b79673d3c88404cc,
title = "Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients",
abstract = "Objectives - To investigate whether the results of optical platelet aggregometry indicate the risk of recurrent ischemic events. Materials and methods - Cerebro- and cardiovascular patients taking aspirin for at least 30 days were studied retrospectively. Ischemic vascular events occurring prior to testing and the presence of vascular risk factors were recorded. Results - 241 subjects were included. Among the 78 patients (32.4{\%}) who displayed recurrent vascular episodes, the age (62.5 ± 10.6 vs. 58.4 ± 11.6, P = 0.009) and the proportion of hypertensives (80.8{\%} vs. 68.1{\%}, P = 0.040) were significantly higher when compared with the participants who exhibited single events. The degree of platelet aggregation did not differ significantly between the patients with and those without recurrent episodes. Logistic regression analysis identified only age (OR 1.033, 95{\%} CI 1.008-1.058, P = 0.010), and not aggregation values, as a risk condition for recurrent vascular episodes. Conclusions - Results of optical platelet aggregometry were not indicative of the risk of recurrent vascular events. The role of conventional risk factors appeared to be more important.",
keywords = "Aspirin resistance, Cerebrovascular diseases, Neuropharmacology, Strokes, Transient ischemic attack, Treatment, Vascular risk factors",
author = "Sztriha, {L. K.} and K. Sas and E. Seres and K. Boda and L. Lenti and G. Csifcsak and N. Kov{\'a}cs and L. V{\'e}csei",
year = "2008",
month = "4",
doi = "10.1111/j.1600-0404.2007.00937.x",
language = "English",
volume = "117",
pages = "250--254",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients

AU - Sztriha, L. K.

AU - Sas, K.

AU - Seres, E.

AU - Boda, K.

AU - Lenti, L.

AU - Csifcsak, G.

AU - Kovács, N.

AU - Vécsei, L.

PY - 2008/4

Y1 - 2008/4

N2 - Objectives - To investigate whether the results of optical platelet aggregometry indicate the risk of recurrent ischemic events. Materials and methods - Cerebro- and cardiovascular patients taking aspirin for at least 30 days were studied retrospectively. Ischemic vascular events occurring prior to testing and the presence of vascular risk factors were recorded. Results - 241 subjects were included. Among the 78 patients (32.4%) who displayed recurrent vascular episodes, the age (62.5 ± 10.6 vs. 58.4 ± 11.6, P = 0.009) and the proportion of hypertensives (80.8% vs. 68.1%, P = 0.040) were significantly higher when compared with the participants who exhibited single events. The degree of platelet aggregation did not differ significantly between the patients with and those without recurrent episodes. Logistic regression analysis identified only age (OR 1.033, 95% CI 1.008-1.058, P = 0.010), and not aggregation values, as a risk condition for recurrent vascular episodes. Conclusions - Results of optical platelet aggregometry were not indicative of the risk of recurrent vascular events. The role of conventional risk factors appeared to be more important.

AB - Objectives - To investigate whether the results of optical platelet aggregometry indicate the risk of recurrent ischemic events. Materials and methods - Cerebro- and cardiovascular patients taking aspirin for at least 30 days were studied retrospectively. Ischemic vascular events occurring prior to testing and the presence of vascular risk factors were recorded. Results - 241 subjects were included. Among the 78 patients (32.4%) who displayed recurrent vascular episodes, the age (62.5 ± 10.6 vs. 58.4 ± 11.6, P = 0.009) and the proportion of hypertensives (80.8% vs. 68.1%, P = 0.040) were significantly higher when compared with the participants who exhibited single events. The degree of platelet aggregation did not differ significantly between the patients with and those without recurrent episodes. Logistic regression analysis identified only age (OR 1.033, 95% CI 1.008-1.058, P = 0.010), and not aggregation values, as a risk condition for recurrent vascular episodes. Conclusions - Results of optical platelet aggregometry were not indicative of the risk of recurrent vascular events. The role of conventional risk factors appeared to be more important.

KW - Aspirin resistance

KW - Cerebrovascular diseases

KW - Neuropharmacology

KW - Strokes

KW - Transient ischemic attack

KW - Treatment

KW - Vascular risk factors

UR - http://www.scopus.com/inward/record.url?scp=40549114259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549114259&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0404.2007.00937.x

DO - 10.1111/j.1600-0404.2007.00937.x

M3 - Article

VL - 117

SP - 250

EP - 254

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

IS - 4

ER -